6Fitzner, KA, Shortridge KF, McGhee SM, et al. Cost-effectiveness study on influenza prevention in Hong Kong [ J ]. Health Policy, 2001,56 ( 3 ) :215-234. 被引量：1
7Black DM, Delmas PD, EasteU R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [ J ]. N Engl J Med, 2007,356 ( 18 ) : 1809 -1822. 被引量：1
8Lyles KW, Colqn-Emerie CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture [ J ]. N Engl J Med ,2007,357 ( 18 ) : 1799-1809. 被引量：1
5Clark W C,Yang J C,Tsui SL,et al.Unidimensional Pain Rating Scales:A Multidimensional Affect and Pain Survey (MAPS) Analysis of What They Really Measure[J].Pain,2002,98(3):241-247. 被引量：1
6Horgas A L.Pain in Nursing Home Residents:Comparison of Residents Self-report a Nursing Assistants Perception[J].Tourual Gerontological Nurs,2001,27(3):44-53. 被引量：1
7Huskisson E C.Measurement of Pain[J].Lancet,1974,2:1127-1131. 被引量：1
8Slack J.Margaret Faut-Callaham,Pain Management[J].Nurs Clinics North Am,1991,26(2):463-476. 被引量：1
9COMPSTON JE,SEEMAN E. Compliance with osteoporosis therapy is the weakest link[ J]. Lancet,2006,368(9540) :973 -974. 被引量：1
10SIRIS ES, HARRIS ST, ROSEN CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women : relationship to vertebral and nonvertebral fractures from 2 US claims databases[J]. Mayo Clin Proc,2006, 81 (8) :1013 - 1022. 被引量：1
